Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine



Rating:

Share or cite this content

Citations should be made in the following way:
Thierry Berghmans (Belgium), Luis Paz-Ares (Spain). Predictive biomarker of immune checkpoint inhibitors efficacy. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Member's Comments

No comment yet.

Related content which might interest you:

• Wearable technologies in respiratory functional assessment
• ERS guideline on withdrawal of inhaled corticosteroids in COPD
• E-cigarettes and smoking cessation: the evidence or the non-evidence